Shionogi says Japan government to buy one million more COVID pill doses
Shionogi previously agreed to sell a million doses of the drug, a protease inhibitor known as ensitrelvir and commercially as…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
French health authority advises against use of Valneva’s COVID-19 vaccine
The snub caused Valneva's shares to fall, with Valneva down by around one per cent during the late morning trading session in…
Novavax to make COVID-19 vaccine shots in Canada
Production of test batches of the protein-based vaccine, Nuvaxovid, will begin at the Montreal manufacturing centre by early 2023
Pfizer to invest over $2.5 billion in manufacturing as COVID-19 vaccine sales decline
The drugmaker said last week it plans to spend more than 1.2 billion euros ($1.26 billion) to expand its Puurs, Belgium…
Bharat Biotech’s iNCOVACC receives primary series and heterologous booster approval
iNCOVACC is the world’s first intra-nasal vaccine for COVID to receive approval for the primary two-dose schedule, and…
Remdesivir could reduce COVID mortality if given early : Study
Researchers from Tokyo Medical and Dental University (TMDU) have found that treatment with remdesivir within nine days of COVID-19…
Gavi rejects Novavax’s claim on COVID vaccine deal breach
More than 18 months after signing the agreement, Novavax has not been able to make a single dose available to COVAX from the…
Novavax ends COVID vaccine sale agreement with Gavi
The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility
Novavax cuts full-year revenue forecast again amid weak demand
The company now expects annual revenue to be near the low end of its prior forecast range of between $2 billion and $2.3 billion
Indian drug 2DG can reduce heart damage by coronavirus, find US researchers
Their findings, based on research with fruit flies and mouse heart cells, were published in 'Communications Biology,' a 'Nature'…
50 million doses of Covaxin set to expire early 2023
Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year,…
Biological E’s Corbevax safe and immunogenic in five to 18 age group
The phase-II/III clinical trial results have been published in peer-reviewed and international journal 'Vaccine'
Moderna COVID vaccine sales forecasts fall short for 2022, 2023
The company did say the 2023 outlook excludes expected contracts with countries such as the US and Japan, and that it anticipated…
US government to test Pfizer’s Paxlovid for long COVID
The Duke Clinical Research Institute is supervising the study, which is scheduled to start on 1st January
Pfizer COVID vaccine price hike seen giving revenue boost for years
The drugmaker, which developed and sells the vaccine with Germany's BioNTech said last week that it is targetting a range of $110…
US FDA authorises Novavax’s COVID vaccine as booster for adults
The regulator's decision is in addition to the earlier clearance for the vaccine as a primary two-shot regimen for those aged 12…
SII stopped Covishield production in Decemeber 2021: Poonawalla
Speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network…
EMA recommends Moderna’s updated Omicron-tailored vaccine
The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months
Moderna says Omicron booster response stays high through three months
The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron